logo
#

Latest news with #Chyawanprash

CIMAP develops new variety to save endangered ayurvedic herb
CIMAP develops new variety to save endangered ayurvedic herb

Time of India

time16-05-2025

  • Health
  • Time of India

CIMAP develops new variety to save endangered ayurvedic herb

1 2 3 4 Lucknow: A critically endangered herb used in your Chyawanprash, Dasmoolarisht and several other ayurvedic tonics and medicines will soon no longer be under threat. You will be able to easily find it in nearby agricultural fields and jungles, just like in the late 80s. The CSIR-Central Institute of Medicinal and Aromatic Plants ( CIMAP ) has accomplished this herb-saving task. The institute's scientists have developed a new, improved variety of the rare, endangered and threatened herb, Prishniparni , a medicinal herb used in Ayurveda for various ailments. It is specifically known for its wound healing, anti-inflammatory and immune-boosting properties. CIMAP released this new and improved variety of Prishniparni (Uraria picta) named ' CIM-Rhoi Gold ' for cultivation. "This plant is very important from a medicinal point of view. It is used in ayurvedic medicines like Dashmularishta, Amritarishta and others, which are prepared for strength-enhancing and women-related health issues, but it has become critically endangered," said chief scientist Dr Birendra Kumar, who, along with his team, developed it after intensive research, development and field trials. He said, "We travelled to seven states: UP, Uttarakhand, Madhya Pradesh, West Bengal, Gujarat, Telangana and Karnataka, and collected it from around 20 districts in these states. W e brought 53 germplasm from these places and cultivated it in our institute at Lucknow, of which only 23 survived and grew. We studied and researched the characteristics of these and developed a new Prishniparni genotype by taking the best traits from available germplasm, specifically the one we brought from Kushinagar that had high Rhoifolin content, a substance found in the herb that has medicinal properties. " "This variety not only has high yield potential, but it also has a high amount of Rhoifolin (1.0-1.5%). Therefore, this variety is capable of meeting the requirements of the ayurvedic and medicinal industries," said CIMAP director Prabodh Kumar Trivedi. He said the institute aims to conserve and promote those medicinal plants which are used in traditional medicine but are on the verge of extinction today. This variety is part of the institute's commitment, under which scientific cultivation of medicinal plants is promoted by providing quality planting material to farmers. It is an important initiative towards preserving India's medicinal heritage, promoting its commercial cultivation and meeting global demands.

Dabur to focus on premiumisation, contemporisation as strategies, shared 7-point formula
Dabur to focus on premiumisation, contemporisation as strategies, shared 7-point formula

Time of India

time14-05-2025

  • Business
  • Time of India

Dabur to focus on premiumisation, contemporisation as strategies, shared 7-point formula

HighlightsDabur India Limited is shifting its strategy towards premiumisation and contemporisation after five years of focusing on market share and consolidation, as stated by Chief Executive Officer Mohit Malhotra. The company's consolidated revenue for the fiscal year 2024-25 was reported at Rs 12,563 crores, with a Profit After Tax of Rs 1,768 crores, reflecting a consolidated revenue growth of 3.6 percent in constant currency terms. Dabur's international business saw significant growth of 19.3 percent in constant currency, while the Indian business experienced a decline of approximately 3.4 percent during the same period. After five years of focusing on market share and consolidation, Dabur India is now actively shifting its strategy towards premiumisation and contemporisation, the company revealed during its latest investor call. Mohit Malhotra, Chief Executive Officer of Dabur India Limited, stated that the company has formulated a fresh 7-point strategy to tap the market in the coming future. Premiumisation is a marketing strategy where companies aim to make their products or services appear more high-end, desirable, and valuable, ultimately leading consumers to pay more for them. Elaborating on the strategies, Dabur's CEO Mohit Malhotra said, "So if you look at the past 4 to 5 years, we've generally focused on increasing market share and consolidating our business in each of the categories." "But premiumisation has been a lesser focus and it was a deliberate attempt because we wanted to bring Dabur Amla back on a growth path and gain market share. Now that we've done all the gaining market shares in Chyawanprash , in Honey, in Amla, in Home Care, and in Skin Care, now it's a 2.0 journey to embark upon premiumisation and contemporisation," he added. "We have identified segments that we will enter for premiumisation, like in Hair Care, we always focused on gaining market share in Dabur Amla. Going forward, you will see our concerted effort on premiumisation of post-bath categories like serum, conditioners, masks, etc.," said the Malhotra. He further added that the last fiscal was a challenging year due to the slowdown in urban consumption, high food inflation and unfavourable season but company's business fundamentals remained strong as they gained market shares across 90 per cent of the portfolio. "Emerging channels comprising modern trade, e-commerce, and quick commerce grew in double digits, although general trade in urban markets remained under pressure," he added. As per Dabur's top official, the company remains optimistic due to the declining food prices and tax cuts going forward. "So going forward, sequential improvement is what we are seeing, but a gradual sequential improvement," he added. According to the information shared by Dabur's top officials, Fiscal year 2024-25 ended with the consolidated revenue of Rs 12,563 crores and Profit After Tax (PAT) of Rs 1,768 crores. Consolidated revenue growth was 3.6 per cent in constant currency terms. During the fourth quarter, consolidated revenue of the company grew by 2.1 per cent in constant currency terms and 0.6 per cent in INR terms. Company's international business exhibited a growth of 19.3 per cent in constant currency and Indian business declined by around 3.4 per cent. The financial results show that Dabur's consolidated bottom line declined by 8.4 per cent on a yearly basis and profit declined 4 per cent to Rs 1,767.63 crore, while the revenue was flat.

Post-Vaccine Fatigue? 3 Ayurvedic Tips to Rebalance Your Body
Post-Vaccine Fatigue? 3 Ayurvedic Tips to Rebalance Your Body

News18

time27-04-2025

  • Health
  • News18

Post-Vaccine Fatigue? 3 Ayurvedic Tips to Rebalance Your Body

Last Updated: While mild tiredness after vaccination is normal, if you continue to experience significant fatigue even a week later, it's wise to consult an Ayurvedic physician Vaccinations shield us against illnesses, but sometimes they leave the body feeling weak and drained. Vaccine fatigue — a lingering sensation of tiredness and weakness — is increasingly common, often lasting up to three-four days, depending on the individual's body type. Ayurveda offers time-tested, natural solutions to restore your energy and bring your body back into balance. Here are three effective Ayurvedic remedies, recommended by Dr. Partap Chauhan, Founder and Director, Jiva Ayurveda, world-renowned Ayurveda Acharya, and author, to help you rise and shine again: 1. Ashwagandha for Energy and Stress Relief Ashwagandha is one of Ayurveda's most revered adaptogens, known for enhancing the body's natural resistance to stress and fatigue. It boosts stamina, elevates energy levels, and promotes mental calmness — making it an excellent support during post-vaccination recovery. By regulating cortisol levels and improving overall vitality, Ashwagandha addresses both physical and mental exhaustion. Try this: Take 1–2 Jiva Ashwagandha tablets daily with food to gradually rebuild your energy and resilience. 2. Chyawanprash to Enhance Immunity and Rebuild Ojas Chyawanprash is a classical Ayurvedic formulation made from over 40 potent herbs, including Amla, a rich source of Vitamin C. It rejuvenates the immune system, repairs tissues, and replenishes ojas — the vital essence that governs immunity, strength, and vitality. A nourishing tonic, Chyawanprash can greatly aid your body's recovery after vaccination, especially when your immune system is under added stress. 3. Light Detox and Self-Care for Gentle Recovery A mild detoxification process can help eliminate excess toxins and restore balance. Simple practices like sipping warm water throughout the day, eating light meals such as khichdi, and drinking ginger tea can soothe digestion and reduce inflammation. Self-abhyanga — a calming self-massage with warm Ayurvedic oil — nurtures the nervous system, enhances circulation, and promotes restorative sleep, both crucial for healing. Try this: Spend 10–15 minutes daily on self-abhyanga, followed by a warm bath to deeply relax the body and mind. When to Seek Expert Help While mild tiredness after vaccination is normal, if you continue to experience significant fatigue even a week later, it's wise to consult an Ayurvedic physician. Prolonged exhaustion may indicate an underlying imbalance or condition that requires personalized care.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store